Search research articles
Contact Us
Filters
Showing results (491-500 of 622) with videos related to
Page
of 63
Sort By:
The Lancet. Oncology
|
April 11, 2014
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial
John Primrose, Stephen Falk, Meg Finch-Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2019
MRI Tumor Regression Grade and Circulating Tumor DNA as Complementary Tools to Assess Response and Guide Therapy Adaptation in Rectal Cancer
Shelize Khakoo, Paul David Carter, Gina Brown, et al.
Circulation
|
February 1, 2015
Transcatheter aortic valve implantation in the United Kingdom: temporal trends, predictors of outcome, and 6-year follow-up: a report from the UK Transcatheter Aortic Valve Implantation (TAVI) Registry, 2007 to 2012
Peter F Ludman, Neil Moat, Mark A de Belder, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 4, 2014
Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy
Paul Ruff, David R Ferry, Radek Lakomỳ, et al.
Journal of Clinical Medicine
|
January 13, 2021
The Mutational Concordance of Fixed Formalin Paraffin Embedded and Fresh Frozen Gastro-Oesophageal Tumours Using Whole Exome Sequencing
Irene Y Chong, Naureen Starling, Alistair Rust, et al.
Journal for Immunotherapy of Cancer
|
November 19, 2019
Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment
Alice Newey, Beatrice Griffiths, Justine Michaux, et al.
Oncotarget
|
January 8, 2019
Genomic loss of heterozygosity and survival in the REAL3 trial
Elizabeth C Smyth, Catherine Cafferkey, Andrea Loehr, et al.
Journal for Immunotherapy of Cancer
|
December 11, 2021
Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with survival
Manish A Shah, David Cunningham, Jean-Philippe Metges, et al.
Lancet (London, England)
|
September 11, 2021
Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study
Martin Hutchings, Rogier Mous, Michael Roost Clausen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 6, 2010
Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study
Jean-Yves Douillard, Salvatore Siena, James Cassidy, et al.
Page
of 63
Search research articles
Search
Showing results (491-500 of 622) with videos related to
Sort By:
Page
of 63
The Lancet. Oncology
|
April 11, 2014
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial
John Primrose, Stephen Falk, Meg Finch-Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2019
MRI Tumor Regression Grade and Circulating Tumor DNA as Complementary Tools to Assess Response and Guide Therapy Adaptation in Rectal Cancer
Shelize Khakoo, Paul David Carter, Gina Brown, et al.
Circulation
|
February 1, 2015
Transcatheter aortic valve implantation in the United Kingdom: temporal trends, predictors of outcome, and 6-year follow-up: a report from the UK Transcatheter Aortic Valve Implantation (TAVI) Registry, 2007 to 2012
Peter F Ludman, Neil Moat, Mark A de Belder, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 4, 2014
Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy
Paul Ruff, David R Ferry, Radek Lakomỳ, et al.
Journal of Clinical Medicine
|
January 13, 2021
The Mutational Concordance of Fixed Formalin Paraffin Embedded and Fresh Frozen Gastro-Oesophageal Tumours Using Whole Exome Sequencing
Irene Y Chong, Naureen Starling, Alistair Rust, et al.
Journal for Immunotherapy of Cancer
|
November 19, 2019
Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment
Alice Newey, Beatrice Griffiths, Justine Michaux, et al.
Oncotarget
|
January 8, 2019
Genomic loss of heterozygosity and survival in the REAL3 trial
Elizabeth C Smyth, Catherine Cafferkey, Andrea Loehr, et al.
Journal for Immunotherapy of Cancer
|
December 11, 2021
Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with survival
Manish A Shah, David Cunningham, Jean-Philippe Metges, et al.
Lancet (London, England)
|
September 11, 2021
Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study
Martin Hutchings, Rogier Mous, Michael Roost Clausen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 6, 2010
Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study
Jean-Yves Douillard, Salvatore Siena, James Cassidy, et al.
Page
of 63